IRS Hopes GSK’s $3.4 Bil. Transfer Pricing Settlement Is Just The Beginning
Executive Summary
The Internal Revenue Service's multi-billion dollar settlement with GlaxoSmithKline over transfer pricing is a milestone for the agency in its efforts to better regulate the practice